Financial & competing interests disclosure
The study by Acosta et al. was funded by the Department of Defense W81XWH-11-1-0634, the University of South Florida Signature Interdisciplinary Program in Neuroscience funds, the University of South Florida and Veterans Administration Reintegration Funds and the University of South Florida Neuroscience Collaborative Program. PR Sanberg and CV Borlongan serve as consultant and founder, respectively, of Saneron CCEL Therapeutics, Inc. CV Borlongan is funded by the National Institutes of Health (1R01NS071956-01A1) and James and Esther King Biomedical Research Foundation (1KG01-33966). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.